Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Kenshiro Takemoto is a pioneering urologic surgeon whose research centers on advancing robotic surgery and improving patient outcomes after prostate cancer treatment. His work with the hinotori™ Surgical Robot System has established new benchmarks for safety and effectiveness in urologic oncology, including robot-assisted radical prostatectomy (RARP) and partial nephrectomy. Dr. Takemoto’s major contributions include demonstrating the long-term efficacy of low-intensity extracorporeal shock wave therapy (LIESWT) for penile rehabilitation after RARP, a finding with 7 citations that offers hope for sexual function recovery. He has also identified predictors of long-term postoperative urinary incontinence through propensity-matched analyses (6 citations), directly informing clinical decision-making. His innovative “centrality angle” nephrometry score provides a novel, simple method to predict tumor complexity and perioperative outcomes in nephron-sparing surgery. With over 35 cumulative citations across his most-cited works, Dr. Takemoto’s research spans from novel surgical techniques to patient quality-of-life improvements, including a randomized trial on catheter-related bladder discomfort. His work exemplifies the integration of cutting-edge technology with compassionate, patient-centered care in modern urology.